Parenteral Drug Association
FDANonrulemakingFDA-2021-D-0432

Microbiological Quality Considerations in Non-Sterile Drug Manufacturing; Draft Guidance for Industry; Availability

RIN
Last modified
Dec 30, 2021
Comment window
closed 1672d ago
Parenteral Drug Association filings
1

Activity

Parenteral Drug Association filed 1 comment on this docket between Dec 29, 2021 and Dec 29, 2021. 1 other organizations filed here. The comment window closed 1672d ago.

What Parenteral Drug Association filed (1)

Dec 29, 2021· Comment from Parenteral Drug Association· FDA-2021-D-0432-0017

PDA Comments to Docket No. FDA–2021–D–0432

Abstract

No abstract recorded.

View on regulations.gov →
Microbiological Quality Considerations in Non-Sterile Drug Manufacturing; Draft Guidance for Industry; Availability (FDA) — Parenteral Drug Association | OpenPolis